Cargando…
Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness
BACKGROUND: People with severe mental illness (SMI) show significantly shorter life expectancy, mostly due to more prevalent cardiovascular disease. Although age is a prominent contributor to contemporary risk assessment and SMI usually affects younger people, these assessments still do not reveal t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066984/ https://www.ncbi.nlm.nih.gov/pubmed/30083385 http://dx.doi.org/10.1192/bjo.2018.34 |
_version_ | 1783343070067032064 |
---|---|
author | Emmerink, Daniëlle Bakker, Sybiel Van Bemmel, Thomas Noorthoorn, Eric O. Naarding, Paul |
author_facet | Emmerink, Daniëlle Bakker, Sybiel Van Bemmel, Thomas Noorthoorn, Eric O. Naarding, Paul |
author_sort | Emmerink, Daniëlle |
collection | PubMed |
description | BACKGROUND: People with severe mental illness (SMI) show significantly shorter life expectancy, mostly due to more prevalent cardiovascular disease. Although age is a prominent contributor to contemporary risk assessment and SMI usually affects younger people, these assessments still do not reveal the actual risk. By assessing advanced glycation end products (AGEs), cardiovascular risk can be assessed independent of age. AIMS: To establish whether detection of AGEs with the AGE-reader will give a more accurate cardiovascular risk assessment in people with SMI. METHOD: We compared assessment with the AGE-reader with that of the Systematic Coronary Risk Evaluation (SCORE) table in a group of 120 patients with SMI. RESULTS: The AGE-reader showed an increased cardiovascular risk more often than the SCORE table, especially in the youngest group. CONCLUSIONS: Because of its ease of use and substantiation by studies done on other chronic diseases, we advocate use of the AGE-reader in daily care for patients with SMI to detect cardiovascular risk as early as possible. However, the findings of the current study should be evaluated with caution and should be seen as preliminary findings that require confirmation by a prospective longitudinal cohort study with a substantial follow-up observation period. DECLARATION OF INTEREST: None. |
format | Online Article Text |
id | pubmed-6066984 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60669842018-08-06 Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness Emmerink, Daniëlle Bakker, Sybiel Van Bemmel, Thomas Noorthoorn, Eric O. Naarding, Paul BJPsych Open Papers BACKGROUND: People with severe mental illness (SMI) show significantly shorter life expectancy, mostly due to more prevalent cardiovascular disease. Although age is a prominent contributor to contemporary risk assessment and SMI usually affects younger people, these assessments still do not reveal the actual risk. By assessing advanced glycation end products (AGEs), cardiovascular risk can be assessed independent of age. AIMS: To establish whether detection of AGEs with the AGE-reader will give a more accurate cardiovascular risk assessment in people with SMI. METHOD: We compared assessment with the AGE-reader with that of the Systematic Coronary Risk Evaluation (SCORE) table in a group of 120 patients with SMI. RESULTS: The AGE-reader showed an increased cardiovascular risk more often than the SCORE table, especially in the youngest group. CONCLUSIONS: Because of its ease of use and substantiation by studies done on other chronic diseases, we advocate use of the AGE-reader in daily care for patients with SMI to detect cardiovascular risk as early as possible. However, the findings of the current study should be evaluated with caution and should be seen as preliminary findings that require confirmation by a prospective longitudinal cohort study with a substantial follow-up observation period. DECLARATION OF INTEREST: None. Cambridge University Press 2018-07-25 /pmc/articles/PMC6066984/ /pubmed/30083385 http://dx.doi.org/10.1192/bjo.2018.34 Text en © The Royal College of Psychiatrists 2018 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Papers Emmerink, Daniëlle Bakker, Sybiel Van Bemmel, Thomas Noorthoorn, Eric O. Naarding, Paul Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness |
title | Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness |
title_full | Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness |
title_fullStr | Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness |
title_full_unstemmed | Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness |
title_short | Skin autofluorescence assessment of cardiovascular risk in people with severe mental illness |
title_sort | skin autofluorescence assessment of cardiovascular risk in people with severe mental illness |
topic | Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066984/ https://www.ncbi.nlm.nih.gov/pubmed/30083385 http://dx.doi.org/10.1192/bjo.2018.34 |
work_keys_str_mv | AT emmerinkdanielle skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness AT bakkersybiel skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness AT vanbemmelthomas skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness AT noorthoornerico skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness AT naardingpaul skinautofluorescenceassessmentofcardiovascularriskinpeoplewithseverementalillness |